Clinical Trials Browser

Phase 1/2 × Leukemia × lestaurtinib × Clear all

NCT00469859 2017-03-15

Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1/2 Completed

14 enrolled 9 charts

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Leukemia, Myeloid, Acute